Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yadi Zhou

Showing results (71-80 of 84) with videos related to

Pageof 9
Sort By:
Cell Reports. Medicine|October 12, 2022
Transcriptomics-based network medicine approach identifies metformin as a repurposable drug for atrial fibrillationJessica C Lal, Chengsheng Mao, Yadi Zhou, et al.
Cell Reports|November 30, 2022
Interpretable deep learning translation of GWAS and multi-omics findings to identify pathobiology and drug repurposing in Alzheimer's diseaseJielin Xu, Chengsheng Mao, Yuan Hou, et al.
Plos Medicine|August 2, 2021
Cardiac risk stratification in cancer patients: A longitudinal patient-patient network analysisYuan Hou, Yadi Zhou, Muzna Hussain, et al.
Molecular Cancer|April 29, 2024
Deubiquitination of CDC6 by OTUD6A promotes tumour progression and chemoresistanceJianfeng Cui, Xiaochen Liu, Qinghong Shang, et al.
Journal of the American Heart Association|November 26, 2020
Machine Learning-Based Risk Assessment for Cancer Therapy-Related Cardiac Dysfunction in 4300 Longitudinal Oncology PatientsYadi Zhou, Yuan Hou, Muzna Hussain, et al.
Journal of the American Heart Association|December 11, 2025
PrevCardioOncAI: Machine Learning Algorithms for Predicting Cardiovascular Disease in Cancer SurvivorsSherry-Ann Brown, Michelle Z Fang, Rodney Sparapani, et al.
Research Square|June 9, 2022
A comprehensive SARS-CoV-2-human protein-protein interactome network identifies pathobiology and host-targeting therapies for COVID-19Yadi Zhou, Yuan Liu, Shagun Gupta, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 6, 2024
Single-microglia transcriptomic transition network-based prediction and real-world patient data validation identifies ketorolac as a repurposable drug for Alzheimer's diseaseJielin Xu, Wenqiang Song, Zhenxing Xu, et al.
Nature Biotechnology|October 10, 2022
A comprehensive SARS-CoV-2-human protein-protein interactome reveals COVID-19 pathobiology and potential host therapeutic targetsYadi Zhou, Yuan Liu, Shagun Gupta, et al.
Biorxiv : the Preprint Server for Biology|August 2, 2024
γ-aminobutyric acid receptor B signaling drives glioblastoma in females in an immune-dependent mannerAsmita Pathak, Sravya Palasalava, Maxon V Knott, et al.
Pageof 9

Showing results (71-80 of 84) with videos related to

Sort By:
Pageof 9
Cell Reports. Medicine|October 12, 2022
Transcriptomics-based network medicine approach identifies metformin as a repurposable drug for atrial fibrillationJessica C Lal, Chengsheng Mao, Yadi Zhou, et al.
Cell Reports|November 30, 2022
Interpretable deep learning translation of GWAS and multi-omics findings to identify pathobiology and drug repurposing in Alzheimer's diseaseJielin Xu, Chengsheng Mao, Yuan Hou, et al.
Plos Medicine|August 2, 2021
Cardiac risk stratification in cancer patients: A longitudinal patient-patient network analysisYuan Hou, Yadi Zhou, Muzna Hussain, et al.
Molecular Cancer|April 29, 2024
Deubiquitination of CDC6 by OTUD6A promotes tumour progression and chemoresistanceJianfeng Cui, Xiaochen Liu, Qinghong Shang, et al.
Journal of the American Heart Association|November 26, 2020
Machine Learning-Based Risk Assessment for Cancer Therapy-Related Cardiac Dysfunction in 4300 Longitudinal Oncology PatientsYadi Zhou, Yuan Hou, Muzna Hussain, et al.
Journal of the American Heart Association|December 11, 2025
PrevCardioOncAI: Machine Learning Algorithms for Predicting Cardiovascular Disease in Cancer SurvivorsSherry-Ann Brown, Michelle Z Fang, Rodney Sparapani, et al.
Research Square|June 9, 2022
A comprehensive SARS-CoV-2-human protein-protein interactome network identifies pathobiology and host-targeting therapies for COVID-19Yadi Zhou, Yuan Liu, Shagun Gupta, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 6, 2024
Single-microglia transcriptomic transition network-based prediction and real-world patient data validation identifies ketorolac as a repurposable drug for Alzheimer's diseaseJielin Xu, Wenqiang Song, Zhenxing Xu, et al.
Nature Biotechnology|October 10, 2022
A comprehensive SARS-CoV-2-human protein-protein interactome reveals COVID-19 pathobiology and potential host therapeutic targetsYadi Zhou, Yuan Liu, Shagun Gupta, et al.
Biorxiv : the Preprint Server for Biology|August 2, 2024
γ-aminobutyric acid receptor B signaling drives glioblastoma in females in an immune-dependent mannerAsmita Pathak, Sravya Palasalava, Maxon V Knott, et al.
Pageof 9